Condition

Left Ventricular Systolic Dysfunction

ClinicalTrials.gov condition label

Explore related research

Search across original and mapped records

Search results distinguish clinical terminology from original registry names. Shared trial participation does not imply treatment or approval.

How to interpret these research links

Connected source records

This is the original ClinicalTrials.gov condition label, found in 18 distinct published trials. It is kept separate from a MONDO disease identifier until a specific normalization is supported. Related interventions are co-recorded in studies; they are not medical recommendations.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Clinical trials18
Recruiting4
Common interventions21
Lead sponsors shown15
Advertisement

Clinical trials

18 shown
A Study to Learn More About How Safe Finerenone is, When it is Taken for a Longer Time With Standard Treatment, in Children and Young Adults With Heart Failure and Left Ventricular Systolic DysfunctionNCT07192952 · 2026-06-01
RECRUITING
A Study to Learn More About How Well Finerenone Works, How Safe it is, and How it Moves Into, Through, and Out of the Body Compared to Placebo When Taken With Standard Treatment in Children With Heart Failure and Left Ventricular Systolic DysfunctionNCT07188805 · 2025-11-19
RECRUITING
Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart FailureNCT06270498 · 2024-03-14
RECRUITING
Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)NCT05714085 · 2023-05-31
RECRUITING
Hyperkalaemia and Its Impact on Therapy with RAASiNCT04249648 · 2021-07-12
COMPLETED
The Relationship Between Inflammatory ARTritis and CArdiac DIseAseNCT05647577 · 2021-01-01
ACTIVE_NOT_RECRUITING
Mechanisms and Innovations in Cardiac Resynchronisation TherapyNCT04221763 · 2019-10-15
COMPLETED
How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?NCT03755570 · 2019-06-21
SUSPENDED
Intravenous Iron Treatment in Patients With Heart Failure and Iron Deficiency: IRONMANNCT02642562 · 2016-08-01
COMPLETED
Effects of Linagliptin on Left Ventricular Myocardial DYsfunction in Patients With Type 2 DiAbetes Mellitus and Concentric Left Ventricular GeometryNCT02851745 · 2015-07-01
COMPLETED
Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction.NCT01918215 · 2015-07-01
COMPLETED
COSMIC-HF - Chronic Oral Study of Myosin Activation to Increase Contractility in Heart FailureNCT01786512 · 2013-02-26
COMPLETED
Cardiac Stress in Septic Shock - Biomarkers, Echocardiography and OutcomeNCT01747187 · 2012-10-01
UNKNOWN
Identifying an Ideal Cardiopulmonary Exercise Test ParameterNCT01162083 · 2010-10-01
COMPLETED
Objective Systolic Function Recuperation Assessed by EchocardiographyNCT01086124 · 2010-03-01
COMPLETED
SCD-HeFT 10 Year Follow-upNCT01058837 · 2009-09-01
UNKNOWN
Sleep-Disordered Breathing in Heart Failure - The SchlaHF-RegistryNCT01500759 · 2007-11-01
COMPLETED
CarDiac MagnEtic Resonance for Primary Prevention Implantable CardioVerter DebrillAtor ThErapy: an International Registry (DERIVATE)NCT03352648 · 2007-01-01
UNKNOWN

Common interventions

Trial status mix

COMPLETED9
RECRUITING4
UNKNOWN3
ACTIVE_NOT_RECRUITING1
SUSPENDED1

Phase mix

PHASE34
NA2
PHASE22
PHASE42
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.